Prapela


Overview

Prapela is introducing a $150 next gen baby box with technology proven to help drug-exposed infants. Neonatal abstinence syndrome (NAS) is our fastest growing pediatric health problem. The Department of Health & Human Services, responsible by law to address NAS, is prioritizing non-pharmacological approaches and solutions to help after discharge. Designed to be used in the hospital and taken home, we have the right product at the right time.

Video Pitch


Management Team

Chief Executive Officer & Co-Founder

John Konsin

A 2x CEO, John has held leadership and executive positions at 4 different Fortune 500 companies and one FTSE 100 company. He has led or assisted in the generation of more than $5.4 billion in revenue and launched over 100 products. Early in his career John developed his talents as a Marketing Analyst and Product Manager at 3M and Kimberly-Clark - two of the most successful global marketing companies in the World.

Chief Technology Officer & Co-Founder

Jim Niemi

25 Years R&D Experience 7 years at the Wyss Institute at Harvard University developing and refining the SRS infant product. Previously he was VP of Research at a neuro-stim tech company. Operational management experience includes research and development, manufacturing, quality, clinical, regulatory, and intellectual property. Deep expertise in neuromuscular stimulation and the development of electromechanical systems.

Head of Europe

Karen Browne

Karen, a pediatric nurse by training, has over 20 years experience in the development, launch and commercial mangement of medical devices with both multi-national and start-up companies.